Betamethasone / calcipotriene topical Pregnancy and Breastfeeding Warnings

Betamethasone / calcipotriene topical is also known as: Dovobet, Taclonex, Taclonex Scalp

Betamethasone / calcipotriene topical Pregnancy Warnings

Animal studies have not been reported with betamethasone-calcipotriene topical. Animal studies have revealed evidence of teratogenicity with corticosteroids administered systemically at relatively low doses. Betamethasone has been shown to be teratogenic when administered subcutaneously in mice and rabbits. Calcipotriene has been shown to be fetotoxic in animals when given systemically. There are no controlled data in human pregnancy. FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

FDA pregnancy category: C Potential benefit should outweigh the potential risk.

Betamethasone / calcipotriene topical Breastfeeding Warnings

Caution is recommended. Excreted into human milk: Unknown Excreted into animal milk: Unknown The effects in the nursing infant are unknown.

It is unknown if there is sufficient systemic absorption with topically administered betamethasone or calcipotriene to have detectable quantities in human milk. Betamethasone-calcipotriene topical suspension should not be used on the breast when nursing.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)